EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 24 / No 6-7 (Juin-Juillet 2008) Med Sci (Paris), 24 6-7 (2008) 659-664 References
Free Access
Issue
Med Sci (Paris)
Volume 24, Number 6-7, Juin-Juillet 2008
Page(s) 659 - 664
Section Recherche et partenariat
DOI https://doi.org/10.1051/medsci/20082467659
Published online 15 June 2008
  1. Takeuchi H, Matsui Y, Sugihara H, et al. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 2005; 303 : 160–70. [Google Scholar]
  2. Zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery - Drug release and release mechanism. Eur J Pharm Biopharm 1998; 45 : 149–55. [Google Scholar]
  3. Lamprecht A, Saumet JL, Roux J, Benoit JP. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 2004; 278 : 407–14. [Google Scholar]
  4. Peltier S, Oger JM, Lagarce F, et al. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm Res 2006; 23 : 1243–50. [Google Scholar]
  5. Gao ZG, Choi HG, Shin HJ, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm 1998; 161 : 75–86. [Google Scholar]
  6. Couvreur P. Polyalkylcyanoacrylates as colloidal drug carriers. Crit Rev Ther Drug Carrier Syst 1988; 5 : 1–20. [Google Scholar]
  7. Italia JL, Bhatt DK, Bhardwaj V, et al. PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral. J Control Release 2007; 119 : 197–206. [Google Scholar]
  8. Hombreiro Perez M, Zinutti C, Lamprecht A, et al. The preparation and evaluation of poly([epsilon]-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug. J Control Release 2000; 65 : 429–38. [Google Scholar]
  9. Damgé C, Michel C, Aprahamian M, Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 1988; 37 : 246–51. [Google Scholar]
  10. Varela MC, Guzman M, Molpeceres J, et al. Cyclosporine-loaded polycaprolactone nanoparticles : immunosuppression and nephrotoxicity in rats. Eur J Pharm Sci 2001; 12 : 471–8. [Google Scholar]
  11. Alonso MJ, Prego C, Garcia-Fuentes M. Polysaccharide-based nanoparticles as carriers for drug and vaccine delivery. In : Domb AJ, Tabata Y, Kumar MNV, Farber S, eds. Nanoparticles for pharmaceutical applications. New York : American Scientific Publishers, 2007 : 135–50. [Google Scholar]
  12. Rajaonarivony M, Vauthier C, Couarraze G, et al. Development of a new drug carrier made from alginate. J Pharm Sci 1993; 82 : 912–8. [Google Scholar]
  13. Jedestrom G, Andersson A, Grasjö J, Sjöholm I. Formulating insulin for oral administration : preparation of hyaluronan-insulin complex. Pharm Res 2004; 21 : 2040–7. [Google Scholar]
  14. Sarmento B, Ribeiro A, Veiga F, et al. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007; 24 : 2198–206. [Google Scholar]
  15. Pan Y, Li YJ, Zhao HY, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002; 249 : 139–47. [Google Scholar]
  16. Janes KA, Fresneau MP, Marazuela A, et al. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 2001; 73 : 255–67. [Google Scholar]
  17. Wawrezinieck A. Élaboration d’un nouveau vecteur pharmaceutique complexe pour l’administration par voie orale d’un peptide protecteur contre le lupus érythémateux disséminé. Thèse pour l’obtention du grade de docteur de l’université Louis Pasteur de Strasbourg, 2007. [Google Scholar]
  18. Jung T, Kamm W, Breitenbach A, et al. Biodegradable nanoparticles for oral delivery of peptides : is there a role for polymers to affect mucosal uptake ? Eur J Pharm Biopharm 2000; 50 : 147–60. [Google Scholar]
  19. Bravo-Osuna I, Vauthier C, Farabollini A, et al. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007; 28 : 2233–43. [Google Scholar]
  20. Bertholon I, Ponchel G, Labarre D, et al. Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide. J Nanosci Nanotechnol 2006; 6 : 3102–9. [Google Scholar]
  21. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery : method to study bioadhesion. Int J Pharm 1984; 19 : 107–27. [Google Scholar]
  22. Ponchel G, Montisci MJ, Dembri A, et al. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur J Pharm Biopharm 1997; 44 : 25–31. [Google Scholar]
  23. Bernkop-Schnürch A. Thiomers : a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005; 57 : 1569–82. [Google Scholar]
  24. Montisci MJ, Dembri A, Giovannuci G, et al. Gastrointestinal transit and mucoadhesion of colloidal suspensions of lycopersicon esculentum L. and lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharm Res 2001; 18 : 829–37. [Google Scholar]
  25. Russell-Jones GJ, Arthur L, Walker H. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. Int J Pharm 1999; 179 : 247–55. [Google Scholar]
  26. Hussain N, Florence AT. O-3 Invasin-induced oral uptake of nanospheres: utilising bacterial mechanisms of epithelial cell entry. J Control Release 1996; 41 : S3–4. [Google Scholar]
  27. Yin Y, Chen D, Qiao M, et al. Lectin-conjugated PLGA nanoparticles loaded with thymopentin: Ex vivo bioadhesion and in vivo biodistribution. J Control Release 2007; 123 : 27–38. [Google Scholar]
  28. Aprahamian M, Michel C, Humbert W, et al. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biol Cell 1987; 61 : 69–76. [Google Scholar]
  29. Jani PU, Florence AT, McCarthy DE. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int J Pharm 1992; 84 : 245–52. [Google Scholar]
  30. Eldridge JH, Hammond CJ, Meulbroek JA, et al. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer’s patches. J Control Release 1990; 11: 205–14. [Google Scholar]
  31. Jenkins PG, Howard KA, Blackball NW, et al. Microparticulate absorption from the rat intestine. J Control Release 1994; 29 : 339–50. [Google Scholar]
  32. Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastro-intestinal tract. Adv Drug Deliv Rev 1998; 44 : 25–31. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.